SE7610501L - Nya n-aryl-n(1-l-4-piperidinyl)-arylacetamider - Google Patents

Nya n-aryl-n(1-l-4-piperidinyl)-arylacetamider

Info

Publication number
SE7610501L
SE7610501L SE7610501A SE7610501A SE7610501L SE 7610501 L SE7610501 L SE 7610501L SE 7610501 A SE7610501 A SE 7610501A SE 7610501 A SE7610501 A SE 7610501A SE 7610501 L SE7610501 L SE 7610501L
Authority
SE
Sweden
Prior art keywords
arylacetamides
piperidinyl
aryl
new
formula
Prior art date
Application number
SE7610501A
Other languages
English (en)
Other versions
SE427839B (sv
Inventor
S Sanczuk
H K F Hermans
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SE7610501L publication Critical patent/SE7610501L/sv
Publication of SE427839B publication Critical patent/SE427839B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7610501A 1975-09-23 1976-09-22 Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider SE427839B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61513175A 1975-09-23 1975-09-23
US71375676A 1976-08-12 1976-08-12

Publications (2)

Publication Number Publication Date
SE7610501L true SE7610501L (sv) 1977-03-24
SE427839B SE427839B (sv) 1983-05-09

Family

ID=27087421

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7610501A SE427839B (sv) 1975-09-23 1976-09-22 Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider

Country Status (29)

Country Link
JP (1) JPS6016417B2 (sv)
AT (1) AT363935B (sv)
AU (1) AU510029B2 (sv)
BG (1) BG27543A3 (sv)
CA (1) CA1068271A (sv)
CH (1) CH628623A5 (sv)
CS (1) CS222663B2 (sv)
DE (1) DE2642856A1 (sv)
DK (1) DK150478C (sv)
ES (1) ES451768A1 (sv)
FI (1) FI61482C (sv)
FR (1) FR2325377A1 (sv)
GB (1) GB1539473A (sv)
GR (1) GR58469B (sv)
HU (1) HU172964B (sv)
IE (1) IE43802B1 (sv)
IL (1) IL50522A (sv)
IT (1) IT1073893B (sv)
LU (1) LU75837A1 (sv)
NL (1) NL187267C (sv)
NO (1) NO147672C (sv)
NZ (1) NZ181972A (sv)
PH (1) PH12497A (sv)
PL (2) PL117323B1 (sv)
PT (1) PT65631B (sv)
RO (1) RO70079A (sv)
SE (1) SE427839B (sv)
SU (1) SU747424A3 (sv)
YU (1) YU39973B (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA765684B (en) * 1975-09-23 1978-04-26 Janssen Pharmaceutica Nv Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS62260786A (ja) * 1986-05-08 1987-11-13 株式会社ヘキトク 燻瓦の製造ラインにおける焼成工程後の表面仕上げ装置
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
JO2642B1 (en) 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
AU2008240727C1 (en) * 2007-04-23 2013-10-03 Janssen Pharmaceutica N.V. Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
CN101663292A (zh) 2007-04-23 2010-03-03 詹森药业有限公司 作为快速解离的多巴胺2受体拮抗剂的4-烷氧基哒嗪衍生物
CA2682671C (en) 2007-04-23 2015-11-17 Janssen Pharmaceutica N.V. Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
CN102159554B (zh) 2008-07-03 2014-09-24 詹森药业有限公司 作为5-ht6受体拮抗剂的取代的6-(1-哌嗪基)-哒嗪
LT2307374T (lt) 2008-07-31 2017-04-25 Janssen Pharmaceutica Nv Piperazin-1-il-trifluormetil-pakeistieji piridinai kaip greitai disocijuojantys dopamino 2 receptoriaus antagonistai

Also Published As

Publication number Publication date
GR58469B (en) 1977-10-14
FR2325377B1 (sv) 1980-04-18
HU172964B (hu) 1979-01-28
PH12497A (en) 1979-04-05
RO70079A (ro) 1982-10-26
LU75837A1 (sv) 1977-05-04
JPS5239683A (en) 1977-03-28
FI61482C (fi) 1982-08-10
NZ181972A (en) 1978-07-28
CH628623A5 (en) 1982-03-15
AU510029B2 (en) 1980-06-05
DE2642856C2 (sv) 1990-06-21
AU1787876A (en) 1978-03-23
PL192578A1 (pl) 1979-02-26
ES451768A1 (es) 1978-05-01
FI762698A (sv) 1977-03-24
NO763054L (no) 1977-03-24
JPS6016417B2 (ja) 1985-04-25
BG27543A3 (en) 1979-11-12
SU747424A3 (ru) 1980-07-23
CS222663B2 (en) 1983-07-29
NO147672C (no) 1983-05-25
FI61482B (fi) 1982-04-30
YU39973B (en) 1985-06-30
PL117323B1 (en) 1981-07-31
IL50522A (en) 1979-09-30
NL187267B (nl) 1991-03-01
IE43802B1 (en) 1981-06-03
SE427839B (sv) 1983-05-09
NL7610513A (nl) 1977-03-25
DK150478C (da) 1987-10-05
YU233676A (en) 1983-01-21
CA1068271A (en) 1979-12-18
IE43802L (en) 1977-03-23
IT1073893B (it) 1985-04-17
GB1539473A (en) 1979-01-31
PT65631A (en) 1976-10-01
ATA702976A (de) 1981-02-15
PT65631B (en) 1978-07-05
DK427876A (da) 1977-03-24
NL187267C (nl) 1991-08-01
DE2642856A1 (de) 1977-03-24
FR2325377A1 (fr) 1977-04-22
DK150478B (da) 1987-03-09
IL50522A0 (en) 1976-11-30
NO147672B (no) 1983-02-14
AT363935B (de) 1981-09-10

Similar Documents

Publication Publication Date Title
DK136714B (da) Analogifremgangsmåde til fremstilling af substituerede piperidinderivater eller syreadditionssalte deraf.
SE7612366L (sv) Nya hydroxibensylmalonsyra-derivat.
DK135124B (da) Analogifremgangsmade til fremstilling af 1-(3-(naphth-1-yl-oxy)-2-hydroxypropyl)-)-piperazinderivater eller syreadditionssalte heraf
SE434394B (sv) Analogiforfarande for framstellning av kinolonalkansyraderivat
SE7604052L (sv) Nya erytromycinderivat och forfarande for framstellning derav
SE7703842L (sv) Nya piperazin- och piperinderivat
NO142400C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, nye benzimidazolinon-derivater
SE7610501L (sv) Nya n-aryl-n(1-l-4-piperidinyl)-arylacetamider
SE7714374L (sv) 1,4-dihydropyridinforbindelser
SE7514271L (sv) Sett att framstella nya 1,3-disubstituerade propanol-(2)-derivat
SE7604476L (sv) Forfarande for framstellning av 1-(3,3,3-triarylpropyl)-4-fenyl-4-piperidinmetanolforeningar
BG26526A3 (bg) Метод за получаване на 1-(бензазолилалкил)пиперидинови производни
SE422065B (sv) Forfarande for framstellning av nya derivat av tiazolo-(3,4-b)-isokinolin
SE7604093L (sv) Anorexa foreningar
SE7811455L (sv) 2-imino-imidazolidin-derivat
GB1471847A (en) Dibenzofuran derivatives
SE7506757L (sv) Forfarande for framstellning av nya heterocykliska foreningar.
SU674671A3 (ru) Способ получени производных пирролидина
SE7508793L (sv) Antibiotiska derivat av xk-62-2 samt forfarande for framstellning derav
SE7612961L (sv) Tienamycinderivat
SE7701845L (sv) Forfarande for framstellning av l-sulfonyl-5(6)-substituerade bensimidazoler
ES398080A1 (es) Procedimiento para la preparacion de derivados de 1-vinil- carbonil-piperazina.
ES391768A1 (es) Procedimiento para la preparacion de derivados de tropan-3-ol.
SE7506729L (sv) Forfarande for framstellning av nya substituerade 1-(2',4',6'-trihydrofenyl)-propandion-(1,2)-foreningar
BG35040A3 (en) Method for preparing a benzoimic derivative of 2- (2, 6'- dichlorphenylamino)- 2- imidazoline and its salt

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7610501-4

Effective date: 19910409

Format of ref document f/p: F